Robert “Bob” Cashman has been named director of new business development for the east coast market of OSO BioPharmaceuticals Manufacturing. Mr. Cashman will identify and nurture new business opportunities throughout the Northeast.

Having spent more than 20 years working within the pharmaceutical and biotechnology contract manufacturing industries, Mr. Cashman brings to OsoBio an expertise in marketing sterile solutions, according to the company.

“Bob has extensive experience and deep knowledge of injectable drug delivery systems and components,” said Milton Boyer, vice president of business development and sales at OsoBio. “Such expertise demonstrates why OsoBio is the contract manufacturer of choice for clients who have complex and custom sterile and injectable needs.”

Prior to joining OsoBio, Mr. Cashman held sales management positions at Catalent Pharma Solutions, Vetter Pharma-Turm, Comar and West Pharmaceutical Services. He is a board member of the PDE Pharmaceutical Trade Organization and a member of the Parenteral Drug Association.